{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:28:39Z","timestamp":1793651319448,"version":"4.5.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.amjmed.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:49:08Z","timestamp":1784875748000},"page":"1586-1590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent advances in cancer immunotherapy"],"prefix":"10.1016","volume":"139","author":[{"given":"Gabriela R.","family":"Esnaola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0706-5371","authenticated-orcid":false,"given":"Edward J.","family":"Goetzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2026.07.012_bib0001","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aec3133","article-title":"Single-cell TCR mapping reveals spatially coordinated T cell states in head and neck cancer","volume":"11","author":"McCord","year":"2026","journal-title":"Sci Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0002","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41586-026-10243-x","article-title":"Thymic health and immunotherapy outcomes in patients with cancer","volume":"652","author":"Bernatz","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0003","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41591-026-04285-x","article-title":"Microbiome modulation in cancer immunotherapy","volume":"32","author":"Pal","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1740345","article-title":"Tailored strategies for improved control of CAR-T cells in multiple myeloma","volume":"17","author":"Bielowski","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1574742","article-title":"CAR-NK cell therapy: promise and challenges in solid tumors","volume":"16","author":"Balkhi","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1322843","article-title":"Editorial: novel insights into CAR T-cell associated neurotoxicity","volume":"14","author":"Bouziana","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1725641","article-title":"Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia\/lymphoma","volume":"17","author":"Schlierkamp-Voosen","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0008","article-title":"Case Report: summary of multiple CAR-T expansions in anti-BCMA\/GPRC5D bispecific CAR-T cell therapy for multiple myeloma","volume":"16","author":"Wei","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0009","first-page":"223","article-title":"Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models","author":"Abrahimi","year":"2026","journal-title":"J Exp Med"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1579925","article-title":"Checkpoint antibody receptor modified ARMed CAR T circumvents the suppressive immunome in GBM","volume":"16","author":"Cook","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1545270","article-title":"SynNotch CAR-T cell, when synthetic biology and immunology meet again","volume":"16","author":"Shirzadian","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0012","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.ymthe.2025.04.037","article-title":"Engineering TME-gated inducible CAR-T cell therapy for solid tumors","volume":"33","author":"Nguyen","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0013","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41586-026-10149-8","article-title":"OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours","volume":"652","author":"Yang","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1707783","article-title":"Data-driven computational modeling of CAR-T cell function","volume":"17","author":"Shah","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0015","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-026-10235-x","article-title":"In vivo site-specific engineering to reprogram T cells","volume":"652","author":"Nyberg","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0016","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41591-026-04244-6","article-title":"In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study","volume":"32","author":"An","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/science.adz8994","article-title":"B lymphocyte protein factories produced by hematopoietic stem cell gene editing","volume":"392","author":"Hartweger","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0018","article-title":"Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects","volume":"16","author":"Wei","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0019","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41591-026-04241-9","article-title":"Clinical development of cancer vaccines","volume":"32","author":"Haanen","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ccell.2026.04.002","article-title":"Bridging clinical gaps in personalized cancer neoantigen vaccines","volume":"44","author":"Khaddour","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0021","first-page":"223","article-title":"Targeting conserved domains of hypoxia-inducible factors for cancer therapy","author":"Salman","year":"2026","journal-title":"J Exp Med"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0022","first-page":"223","article-title":"Targeting Mettl8-Tcf1 axis promotes CD8+ TPEX differentiation and antitumor immunity","author":"Song","year":"2026","journal-title":"J Exp Med"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0023","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.7150\/thno.123285","article-title":"Anti-cancer immune priming with beta-radioligand therapy using a novel high affinity antibody selectively targeting the 4Ig-isoform of B7-H3","volume":"16","author":"Glazer","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.amjmed.2026.07.012_bib26","first-page":"223","article-title":"Antibody-drug conjugates in solid tumors: Efficacy, challenges, and opportunities","author":"Shah","year":"2026","journal-title":"J Exp Med"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads7910","article-title":"CD4(+) T cells impair tumor growth through IL-3 and TNF-dependent vascular damage","volume":"392","author":"Lian","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.amjmed.2026.07.012_bib0025","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/biomedicines11071878","article-title":"LAG-3 inhibitors: novel immune checkpoint inhibitors changing the landscape of immunotherapy","volume":"11","author":"Ibrahim","year":"2023","journal-title":"Biomedicines"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326005292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326005292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:55:54Z","timestamp":1793649354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326005292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0002934326005292"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.07.012","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}